Innovative Bioresearch

Good night, dear friends.I have prepared for you a brief overview of the medical project .And so meet Innovative Bioresearch.Innovative Bioresearch is a private biotechnology company based in Italy. Based scientist and researcher Jonathan FYROM with the aim of introducing innovations in the field of HIV, cancer and regeneration of man! It is an ICO to support AIDS treatment research, as well as to develop an application that provides, on the one hand, a decentralized database for clinical data derived from future human trials, to overcome the limitations of current centralized databases, and on the other, a social platform for a seropositive HIV community and future services. The creators of the project propose to use Salamander fibroblasts in the treatment of dangerous diseases that humanity can not yet cope with.

Among vertebrates urodele amphibians (salamanders) - the only four-legged, with the ability to regenerate complex structures, such as limbs, tail and spinal cord throughout their lives. In addition, it has been shown that the process of regeneration of salamanders eliminates tumors.

Fibroblasts are necessary for the regeneration of Salamander, but the mechanisms underlying the generation, remain unclear. The role of fibroblasts in the regeneration of the limbs of salamanders and their activity can be compared with the role of human fibroblasts. In addition, the question remains whether the Salamander tissue can regenerate and regress tumors in animals with limited ability to regenerate. A better understanding of these processes may lead to the development of new regenerative and anticancer therapies.Traditionally, all data obtained from scientific research are collected in the form of a scientific article published in an independent peer-reviewed scientific journal and usually published in a public database, such as the NIH database ( https: / www .ncbi.nlm.nih.gov / PubMed). When a new therapeutic strategy, such as new cell therapy for HIV, SupT1 cell infusion, goes through several stages of clinical trials, various research teams around the world can conduct research. And once the therapy is finally approved to treat people, different doctors around the world can prescribe treatment to patients. This means that when a research team wants to conduct clinical trials, they need to go through a tedious and time-consuming process of finding all published data from previous studies, read all documents, select useful data, and make every effort to interpret the data to create a Protocol for testing them, personalize it for their patient typology. In fact, each patient may be different individual characteristics (e.g. age, ethnicity, HIV tropism), and hence may require a personalized treatment protocols. And the same problem occurs when clinicians start administering approved treatment to patients; they need to go through all the paperwork and best understand which treatment Protocol to use. As already mentioned, this process of accessing clinical data can be quite tedious and time consuming, but can also lead to human error.* Cancer and AIDS research

• Creation of a decentralized database and its processing
• Create an application that provides the user with complete information, support and services for the treatment of cancer and HIV.
• Issue a token for the purchase of any items: for example, ultra-fast machines from the project's online garage.

Importance of the project: identification of the problem

Traditionally, all data obtained as a result of scientific research are collected in the form of a scientific article, which is published in a scientific journal, which has passed an independent examination, and usually published in a public database.

When a new therapeutic technology, such as innovative cell-based therapies for HIV using the drug for infusion of SupT1 cells, passes through several stages of clinical research, various research groups around the world can carry out the desired experiments. And as soon as the therapy is finally approved for the treatment of people, all doctors around the world begin to prescribe treatment to patients.Possible solution: a decentralized data base using the blockchain for storage of clinical data

A possible solution is to create a decentralized database using blockchain technology. In the process of implementing the project, it is planned to create an application "You are not alone". The application will have a user-friendly interface that allows any doctor conducting a clinical study to enter the data obtained during their tests. Application will allow to drive a wide range of individual parameters for each patient, for example, age, ethnicity, stage of disease progression, viral tropism of HIV, as well as the clinical Protocol used.For research projects, Jonathan Fior works as a lead researcher, thinking about experiments and writing an experimental Protocol. The work is then assigned to a Contract research organization (CRO) that physically performs the experiments. Then Jonathan Fior controls all aspects related to research closely related to CRO. Once the experiments are completed, he analyzes the results and writes a scientific paper, which is published in a scientific journal that has passed the expert evaluation. This means that although their team is not big, they have companies that employ more than 100 people. So they keep a small but strong and excellent team. They publish only open access scientific journals because they believe in free information and do not want this data to be sold.To maximize results and reduce costs, they conduct their highly specialized research, collaborating with modern CRO and institutes.Specific tools for biomedical research involving human beings

Models of humanized mice offer new opportunities for more specific solutions to specific issues. AXENIS introduces a host of new solutions for the scientific community, biotechnological companies and the bio-pharmaceutical industry looking for innovative models of human biological mechanisms in vivo!International supplier of tools for bioreactors
Bertin Bioreagent distributes high quality products all over the world thanks to our international distribution network: test kits, chemicals, antibodies, proteins !The app will also document the progress of our AIDS treatment research project with periodic updates such as articles. This will create a community where people living with HIV can stay alone with the date, comment, share, interact with us, working on the drug, and with each other. Something that creates a bridge between HIV-infected people and research scientists working on the cure. Something that allows the HIV seropositive community and everyone interested to be part of this journey. Something that can send a message that they're not alone in the battle.Hard Cap: 50 million INNBC tokens (including pre-sale)
Payment methods: ETH
INNBC quantity for pre-sale: 20 000 000
INNBC quantity for sale: 30 000 000
INNBC token is token ERC20, released on the Etherum blockchain, and will only
one of the initial limited supply of tokens INNBC. Innovative Bioresearch also intends to use the funds received during the Token sale for further development of the project, payment of wages and future expenses.
Bioresearch will reserve up to 100,000 tokens to support the token economy and these tokens will not be available for sale.
INNBC token can be used as soon as all purchased INNBC tokens are distributed among buyers. In addition, INNBC token holders can sell their tokens to users who need access to THE platform.
The price of the INNBC token is 1EUR (1.23 USD) for 1INNBC, which corresponds to 415INNBC for 1ETH for
More information:
Website: https://www.innovativebioresearch.com
WhitePaper : https://docs.wixstatic.com/ugd/b25952_f15e84ff60ea49879619ed747a40b54e.pdf
ANN Thread: https://bitcointalk.org/index.php?topic=3385669
Twitter: https://twitter.com/InnBioresearch
Facebook: https://www.facebook.com/innovativebioresearch
ANN: https://bitcointalk.org/index.php?topic=3378302.0

Bitcointalk Profile ( jitotomang ) :